申请人:The Upjohn Company
公开号:US03960961A1
公开(公告)日:1976-06-01
This invention relates to novel 4-phenylcyclohexylamines embraced by the formula ##SPC1## Wherein .about. is a generic expression denoting cis and trans stereoconfiguration and mixtures thereof; R is selected from the group consisting of alkyl of from one through four carbon atoms, fluorine, chlorine, bromine, trifluoromethyl, nitro and alkoxy of from one through four carbon atoms; R' and R.sup.1 are selected from the group consisting of hydrogen and alkyl of from one through four carbon atoms; R.sup.2 is selected from the group consisting of hydrogen, alkyl of from one through four carbon atoms, alkanoyl of from one through three carbon atoms, alkylsulfonyl of from one through three carbon atoms, arylsulfonyl of from six through ten carbon atoms, alkylcarbamoyl wherein alkyl is from one through four carbon atoms, alkoxycarbonyl wherein alkyl is from one through four carbon atoms, ring monosubstituted aroylalkyl wherein the substituents have the same meaning as R, above, aryl is from six through ten carbon atoms and alkyl is from one through six carbon atoms and bis (ring monosubstituted) arylalkyl wherein the substituents have the same meaning as R, above, aryl is from six through ten carbon atoms and alkyl is from one through six carbon atoms; R.sup.1 and R.sup.2 when taken together with --N< is a saturated heterocyclic amino radical selected from the group consisting of unsubstituted and monosubstituted pyrrolidino, piperidino, hexamethylenimino, morpholino and piperazino; and an acid addition salt thereof. It also relates to intermediates and processes for the preparation of the aforesaid novel compounds (1) and novel derivatives thereof. The systemic administration to humans and animals of the novel compounds (1) depresses their central nervous systems.
这项发明涉及由以下式 embraced 的新型 4-苯基环己胺 ##SPC1## 其中 .about. 是一个通用表达式,表示顺式和反式立体构型及其混合物;R 选自由一至四个碳原子的烷基、氟、氯、溴、三氟甲基、硝基和由一至四个碳原子组成的烷氧基;R' 和 R.sup.1 选自由一至四个碳原子的氢和烷基;R.sup.2 选自由一至四个碳原子的氢、烷基、由一至三个碳原子组成的烷酰基、由一至三个碳原子组成的烷基磺酰基、由六至十个碳原子组成的芳基磺酰基、烷基氨基甲酰,其中烷基由一至四个碳原子组成,烷氧羰基,其中烷基由一至四个碳原子组成,环中单取代芳酰基烷基,其中取代基的含义与上述的 R 相同,芳基由六至十个碳原子,烷基由一至六个碳原子,以及双(环中单取代)芳基烷基,其中取代基的含义与上述的 R 相同,芳基由六至十个碳原子,烷基由一至六个碳原子;当 R.sup.1 和 R.sup.2 与 --N< 结合在一起时,是选自未取代和单取代吡咯烷基、哌啶基、六亚甲基基氮、吗啉基和哌嗪基的饱和杂环氨基基团;以及其酸盐。它还涉及制备上述新型化合物 (1) 及其新型衍生物的中间体和过程。将这些新型化合物 (1) 系统地给人类和动物静脉注射会抑制其中枢神经系统。